Table 5.

Familial Cerebral Cavernous Malformations: Recommended Surveillance

System/ConcernEvaluationFrequency
CCMs Brain imaging
  • Brain MRI imaging w/standard sequences (T1, T2, FLAIR) & SWI is indicated in persons experiencing new neurologic symptoms.
  • It is debatable whether routine surveillance in the absence of symptoms is helpful. 1
Epilepsy
  • Neurologic & neurosurgical eval
  • EEG
  • Brain imaging
  • If seizures are under control on ASMs, annual follow up w/neurologist is recommended.
  • If the affected person has an exacerbation of a previously quiescent seizure disorder, brain MRI, EEG, & possibly neurosurgical eval should be considered.
  • If epilepsy is intractable despite multiple ASM trials, a neurosurgical eval should be considered.
Headaches Neurologic evalPer standard recommendations
Focal neurologic symptoms
  • Neurologic eval
  • PT & rehab
  • If the affected person has a stable focal neurologic deficit, PT & rehab should be considered.
  • For persistent lower motor neuron facial weakness or double vision, facial reanimation &/or ophthalmologic surgeries to restore function can be considered.
SCCMs Spinal imaging
  • Spinal imaging should be repeated if the affected person has recurrent or worsening symptoms.
  • Debate exists regarding routine surveillance in the absence of new symptoms. 1

CCM = cerebral cavernous malformation; PT = physical therapy; SCCM = spinal cord cavernous malformations; SWI = susceptibility-weighted imaging

1.

From: Familial Cerebral Cavernous Malformations

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.